A Phase 3 study has found that patients with Sickle Cell Disease (SCD) who took a daily dose of the novel drug voxelotor had less anemia and made healthier red blood cells than patients receiving a placebo.
An international study may offer hope to people with a rare and debilitating genetic disorder, PKAN, as well as a potentially new approach to treat other neurodegenerative disorders, such as Alzheimer’s, Parkinson’s disease and multiple sclerosis.
Two-day symposium will bring together scientists from a variety of disciplines to discuss emerging trends in diseases such as Lyme, malaria, dengue, Zika and others that are transmitted by mosquitos, ticks, flies and other arthropod vectors.
Made possible by a $30 million gift from Marc and Lynne Benioff, UCSF announced the launch of the UCSF Benioff Homelessness and Housing Initiative, a new center that will research and identify evidence-based solutions to prevent and end homelessness.
UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.